cell therapy

A team of Chinese scientists has successfully cured a patient’s diabetes using cell therapy, marking a global first. What Happened: The patient, who was at high risk of severe diabetes complications, has been insulin-free for 33 months following the treatment, reported the South China Morning...

Cabaletta Bio Inc (NASDAQ: CABA) has announced 28-day clinical data from the third dose cohort (500 million DSG3-CAART cells) in the DesCAARTes Phase 1 trial for mucosal-dominant pemphigus vulgaris (mPV). The Company observed a dose-dependent increase in DSG3-CAART persistence in...

Kite Pharma, a unit of Gilead Sciences Inc (NASDAQ: GILD) and Shoreline Biosciences Inc, has entered into a strategic partnership to develop novel cell therapies across various cancer targets. The collaboration will focus initially on chimeric antigen receptor (CAR) NK...

Avalon GloboCare Corp (NASDAQ: AVCO) has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock transaction. In connection with the transaction, Avalon will issue 81 million shares of its common stock. The acquisition...

Athenex Inc (NASDAQ: ATNX) shares have risen during premarket trading in reaction to acquiring Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront. Additionally, Kuur shareholders are eligible to receive up to $115 million of milestone...

Bristol-Myers Squibb Co (NYSE: BMY) continues to scale its CAR-T operations with the latest move to open its first cell manufacturing site in Europe and fifth worldwide. BMY is set to build a new cell therapy site in Leiden, the Netherlands. Financial terms were not disclosed....

Nkarta Inc. (NASDAQ: NKTX) announced on Tuesday the underwriters for its initial public offering have completely exercised their overallotment option to purchase 2.1 million additional shares. This brings the biopharmaceutical company's total amount raised in the IPO to $289.8 million. It...